Copper(II) complexes with highly water-soluble L- and D-proline-thiosemicarbazone conjugates as potential inhibitors of Topoisomerase IIα.

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Felix Bacher - (Autor:in)
  • Eva Enyedy - (Autor:in)
  • Antal Rockenbauer - (Autor:in)
  • Gabriella Bognar - (Autor:in)
  • Robert Trondl - (Autor:in)
  • Maria Novak - (Autor:in)
  • Erik Klapproth - , Institut für Pharmakologie und Toxikologie, Universität Wien (Autor:in)
  • Tamas Kiss - (Autor:in)
  • Vladimir Arion - (Autor:in)

Abstract

Two proline-thiosemicarbazone bioconjugates with excellent aqueous solubility, namely, 3-methyl-(S)-pyrrolidine-2-carboxylate-2-formylpyridine thiosemicarbazone [L-Pro-FTSC or (S)-H2L] and 3-methyl-(R)-pyrrolidine-2-carboxylate-2-formylpyridine thiosemicarbazone [D-Pro-FTSC or (R)-H2L], have been synthesized and characterized by elemental analysis, one- and two-dimensional (1)H and (13)C NMR spectroscopy, and electrospray ionization mass spectrometry. The complexation behavior of L-Pro-FTSC with copper(II) in an aqueous solution and in a 30% (w/w) dimethyl sulfoxide/water mixture has been studied via pH potentiometry, UV-vis spectrophotometry, electron paramagnetic resonance, (1)H NMR spectroscopy, and spectrofluorimetry. By the reaction of copper(II) acetate with (S)-H2L and (R)-H2L in water, the complexes [Cu(S,R)-L] and [Cu(R,S)-L] have been synthesized and comprehensively characterized. An X-ray diffraction study of [Cu(S,R)-L] showed the formation of a square-pyramidal complex, with the bioconjugate acting as a pentadentate ligand. Both copper(II) complexes displayed antiproliferative activity in CH1 ovarian carcinoma cells and inhibited Topoisomerase IIα activity in a DNA plasmid relaxation assay.

Details

OriginalspracheEnglisch
FachzeitschriftInorganic chemistry
PublikationsstatusVeröffentlicht - 5 Juli 2013
Peer-Review-StatusJa

Externe IDs

PubMed 23829568
Scopus 84881123922

Schlagworte